CLINICAL OUTCOMES
THE EVOLUTION OF DRUG DELIVERY TECHNOLOGIES
The safe and effective delivery of drugs into the human body is paramount in healthcare. However, only a select few drug candidates successfully meet this challenge, leaving behind a trail of failed attempts with substantial financial costs and significant time wasted.
At Imperial Bioscience, we have developed an innovative solution that has the potential to address this challenge head-on. TheMicroneedle Array Patch (MAP) technology offers a more effective and safe approach to drug delivery for new drug entities and existing treatments, enhancing patient compliance and overall therapeutic outcomes.
SIGNIFICANT
CLINICAL
BENEFITS
The MAP technology is designed to overcome various challenges associated with traditional drug delivery methods and provide several benefits:
VERSATILITY IN DRUG DELIVERY
Dissolvable microarray patches are designed to accommodate solid and liquid drugs. Solid drugs can be incorporated into the patch matrix, while liquid drugs can be formulated into a solution or suspension within the dissolvable material. This versatility allows for a broad range of medications to be delivered using this technology.
NON-INVASIVE AND PAINLESS ADMINISTRATION
Our dissolvable microarray patches provide a non-invasive and painless method of drug administration. The microscale needles on the patch penetrate the outermost layer of the skin, delivering the drug directly into the underlying tissue. This eliminates the need for injections and reduces the associated discomfort, making it more patient-friendly.
CONTROLLED AND PRECISE DRUG RELEASE
The dissolvable microarray patches are designed to release the drug in a controlled and predetermined manner. The rate of drug release can be adjusted by modifying the properties of the patch material. This controlled release mechanism ensures precise dosing and enhances therapeutic efficacy by maintaining therapeutic drug levels over a desired period.
​
ENHANCED STABILITY AND SHELF LIFE
Dissolvable microarray patches can provide improved stability for certain drugs susceptible to degradation or requiring specific storage conditions. The patch acts as a protective barrier, shielding the drug from environmental factors such as light, oxygen, or moisture. This helps maintain the drug's stability, extending its shelf life and preserving its potency.
TARGETED AND LOCALISED THERAPY
The microneedles on the dissolvable microarray patch enable targeted and localised drug delivery. By precisely controlling the depth of needle penetration, the drug can be delivered to specific sites within the skin, offering targeted therapy. This is particularly beneficial for conditions that require localised treatment or specific concentrations at specific locations.
ENHANCED PATIENT COMPLIANCE
Dissolvable microarray patches offer convenience and improved patient compliance. Patients typically self-administered them, eliminating the need for healthcare professional intervention. The simplicity of application and painless administration can encourage patient adherence to medication regimens, leading to improved treatment outcomes.
POTENTIAL FOR CUSTOMISED DOSING PROFILES
Dissolvable microarray patches can be customised to achieve specific dosing profiles. By adjusting the formulation and characteristics of the patch material, drug release kinetics can be tailored to meet individual patient needs. This customisation allows for personalised medicine approaches, optimising therapeutic outcomes.